StepStone Group LP
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 14, 2025), StepStone Group LP reported 16 stock positions worth $97.4 million. Its top holding was Moneylion (ML) at 54.1% of the portfolio, followed by Uipath Class A (PATH, 13.6%) and Draftkings Class A (DKNG, 7.3%). Compared with Q4 2024, it opened 5 new positions, sold out of 3 and reduced 1. The biggest buy was a new position in Rubrik Class A (RBRK) and the biggest sale Draftkings Class A (DKNG, shares −33%).
- Most Recent 13F
- Q2 2026
- Location
- La Jolla, CA
- CIK
- 0001502287
- Portfolio Value
- $97.4M (Q1 2025)
- SEC Filing
- 0000950123-25-005172 ↗ filed May 14, 2025
Holdings Value
Holdings 16 stocks · $97.4M
| ML Moneylion Inc. | 54.09% | 622,931 | $52.7M | No change |
| PATH Uipath Inc. Class A | 13.61% | 1,286,527 | $13.3M | No change |
| DKNG Draftkings Inc. Class A | 7.32% | 214,536 | $7.1M | Reduce -33.3% |
| TRDA Entrada Therapeutics Inc. | 7.07% | 761,277 | $6.9M | No change |
| NEUE Neuehealth Inc. | 3.65% | 525,247 | $3.6M | No change |
| RBRK Rubrik Inc. Class A | 3.37% | 53,838 | $3.3M | New |
| PHAT Phathom Pharmaceuticals Inc. | 2.72% | 422,085 | $2.6M | No change |
| OKUR Onkure Therapeutics Inc. Class A | 2.17% | 491,938 | $2.1M | No change |
| BZ Kanzhun Ltd. - ADR | 2.08% | 105,645 | $2.0M | New |
| HLVX Hillevax Inc. | 1.23% | 826,569 | $1.2M | No change |
| VCSA Vacasa Inc. Class A | 0.81% | 147,261 | $792K | No change |
| FRSH Freshworks Inc. Class A | 0.62% | 42,586 | $601K | New |
| GROV Grove Collaborative Holdings | 0.53% | 380,383 | $514K | No change |
| DOCS Doximity Inc. Class A | 0.45% | 7,497 | $435K | New |
| TNYA Tenaya Therapeutics Inc. | 0.27% | 462,163 | $263K | No change |
| AMPL Amplitude Inc. Class A | 0.02% | 2,235 | $23K | New |
Portfolio Sells Q4 2024 → Q1 2025
Portfolio Buys Q4 2024 → Q1 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 22 | $2.2B | SPCX, STUB, CBRS, XNDU, TMS |
| Q1 2026 | 17 | $207.2M | KRMN, STUB, XNDU, OKUR, PATH |
| Q4 2025 | 22 | $184.1M | STUB, KDK, PATH, KRMN, TRDA |
| Q3 2025 | 15 | $201.5M | STUB, KRMN, PATH, KDK, DKNG |
| Q2 2025 | 14 | $50.4M | PATH, DKNG, RBRK, TRDA, PHAT |
| Q1 2025 | 16 | $97.4M | ML, PATH, DKNG, TRDA, NEUE |
| Q4 2024 | 14 | $114.4M | ML, PATH, TRDA, DKNG, OKUR |
| Q3 2024 | 14 | $274.1M | DNB, ML, RBLX, RKLB, PATH |
| Q2 2024 | 16 | $493.1M | DNB, WKME, ML, RKLB, RBLX |
| Q1 2024 | 21 | $471.6M | DNB, WKME, ML, RKLB, PATH |